Acadia Healthcare (NASDAQ:ACHC) is a leading provider of behavioral healthcare services in the United States, the United Kingdom and Puerto Rico. Since its founding in 2005, Acadia has built a comprehensive delivery system that includes inpatient psychiatric hospitals, residential treatment programs, outpatient clinics and telehealth services. The company specializes in the diagnosis and treatment of mental health disorders, substance use disorders and co-occurring conditions, serving adolescents, adults and older adults through a continuum of care designed to support clinical recovery and community reintegration.
Over the years, Acadia has expanded its footprint through strategic acquisitions and organic growth, incorporating a diverse portfolio of facilities that range from acute care psychiatric hospitals to intensive outpatient and partial hospitalization programs. Key acquisitions include the Psychiatric Solutions transaction in 2010 and the Charter Behavioral Health System acquisition in 2018, which significantly broadened Acadia’s capacity and geographic reach. Today, the company operates more than 200 facilities, staffed by multidisciplinary teams of psychiatrists, psychologists, nurses, social workers and licensed therapists who collaborate to deliver evidence-based treatment modalities and personalized care plans.
Leadership at Acadia Healthcare is guided by Chairman and Chief Executive Officer Irvin D. Cooper, a seasoned executive with over three decades of experience in behavioral healthcare management. Under his direction, the company emphasizes clinical excellence, regulatory compliance and patient safety, while pursuing partnerships with payers, community organizations and academic institutions. Acadia’s mission-driven approach seeks to address the growing demand for mental health and addiction services by innovating treatment models, enhancing access through telepsychiatry and investing in workforce development to meet the evolving needs of the populations it serves.
